Cancer Research Institute (CRI), is a nonprofit organization established in 1953 that is dedicated to advancing scientific research on the immune system with the goal of developing immunotherapies to treat and potentially cure all cancers.
To save more lives and reduce cancer deaths, CRI provides funding to an international community of scientific experts conducting innovative research in immunology and cancer immunotherapy—the most promising approach to cancer treatment to emerge since the advent of chemotherapy in the 1940s. Through this work, which spans the entire spectrum of discovery and drug development, CRI aims to harness the immune system’s innate power to fight all forms of cancer, making possible new, safer, and more effective treatment options.
CRI is at the epicenter of today’s revolutionary breakthroughs in cancer treatment. It was the first nonprofit to establish and nurture the field of cancer immunology, and over the past six decades has attracted to the field thousands of the brightest scientific minds and enabled them to pursue high-risk research that otherwise would have gone unfunded. Its prestigious Scientific Advisory Council, composed of the field’s most notable luminaries, guides all funding decisions, ensuring the highest standards of scientific excellence and greatest potential for impact on cancer treatment.
CRI continues to be an engine of innovation as its scientists forge new discoveries in laboratories and clinics around the world. Through its creation of transformative funding models and strategic application of its resources and unique capabilities, CRI is able to accelerate discovery and speed the development of lifesaving immunotherapies for more cancer patients.
CRI is not a treatment facility and does not provide medical advice. However, as the leader in cancer immunotherapy research, we draw upon our global network of immunotherapy experts to provide trusted information to the public, with a focus on connecting patients and caregivers to cancer immunotherapy clinical trials as well as to other patients that have been treated with immunotherapy.
What makes the Cancer Research Institute unique?
Cancer Research Institute (CRI), is a nonprofit organization established in 1953 that is dedicated to advancing scientific research on the immune system with the goal of developing immunotherapies to treat and potentially cure all…
|Assistant to the Chief Executive Officer||New York, NY||November 20, 2019|